[Current data on GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) in acute myeloid leukemia]. 1992

A de Gentile, and M H Schlageter, and I Krawice, and H Dombret, and Y Najean, and C Chomienne, and M E Toubert
Service de médecine nucléaire, hôpital Saint-Louis, Paris, France.

GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) activates neutrophil, eosinophil, granular, and macrophage precursors through binding to specific receptors. GM-CSF receptor is a member of the "cytokine receptor superfamily", which displays a particular transmembrane structure. It is expressed in small amounts on normal mature blood or medullary cells, with a high affinity. On acute myeloid leukemia blasts (18 patients), our results agree with the review of the literature: GM-CSF receptors are in small amounts, of two types (high and low affinity), with no relation to the FAB classification of leukemias.

UI MeSH Term Description Entries
D003115 Colony-Stimulating Factors Glycoproteins found in a subfraction of normal mammalian plasma and urine. They stimulate the proliferation of bone marrow cells in agar cultures and the formation of colonies of granulocytes and/or macrophages. The factors include INTERLEUKIN-3; (IL-3); GRANULOCYTE COLONY-STIMULATING FACTOR; (G-CSF); MACROPHAGE COLONY-STIMULATING FACTOR; (M-CSF); and GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; (GM-CSF). MGI-1,Macrophage-Granulocyte Inducer,Colony Stimulating Factor,Colony-Stimulating Factor,MGI-1 Protein,Myeloid Cell-Growth Inducer,Protein Inducer MGI,Cell-Growth Inducer, Myeloid,Colony Stimulating Factors,Inducer, Macrophage-Granulocyte,Inducer, Myeloid Cell-Growth,MGI 1 Protein,MGI, Protein Inducer,Macrophage Granulocyte Inducer,Myeloid Cell Growth Inducer
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015470 Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. Leukemia, Myelogenous, Acute,Leukemia, Nonlymphocytic, Acute,Myeloid Leukemia, Acute,Nonlymphocytic Leukemia, Acute,ANLL,Acute Myelogenous Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with Maturation,Acute Myeloid Leukemia without Maturation,Leukemia, Acute Myelogenous,Leukemia, Acute Myeloid,Leukemia, Myeloblastic, Acute,Leukemia, Myelocytic, Acute,Leukemia, Myeloid, Acute, M1,Leukemia, Myeloid, Acute, M2,Leukemia, Nonlymphoblastic, Acute,Myeloblastic Leukemia, Acute,Myelocytic Leukemia, Acute,Myelogenous Leukemia, Acute,Myeloid Leukemia, Acute, M1,Myeloid Leukemia, Acute, M2,Nonlymphoblastic Leukemia, Acute,Acute Myeloblastic Leukemia,Acute Myeloblastic Leukemias,Acute Myelocytic Leukemia,Acute Myelocytic Leukemias,Acute Myelogenous Leukemias,Acute Myeloid Leukemias,Acute Nonlymphoblastic Leukemia,Acute Nonlymphoblastic Leukemias,Acute Nonlymphocytic Leukemia,Acute Nonlymphocytic Leukemias,Leukemia, Acute Myeloblastic,Leukemia, Acute Myelocytic,Leukemia, Acute Nonlymphoblastic,Leukemia, Acute Nonlymphocytic,Leukemias, Acute Myeloblastic,Leukemias, Acute Myelocytic,Leukemias, Acute Myelogenous,Leukemias, Acute Myeloid,Leukemias, Acute Nonlymphoblastic,Leukemias, Acute Nonlymphocytic,Myeloblastic Leukemias, Acute,Myelocytic Leukemias, Acute,Myelogenous Leukemias, Acute,Myeloid Leukemias, Acute,Nonlymphoblastic Leukemias, Acute,Nonlymphocytic Leukemias, Acute
D016184 Receptors, Colony-Stimulating Factor Cell surface receptors for colony stimulating factors, local mediators, and hormones that regulate the survival, proliferation, and differentiation of hemopoietic cells. Colony-Stimulating Factor Receptors,Hematopoietic Growth Factors Receptors,Receptors, Hematopoietic Growth Factors,CSF Receptors,Colony-Stimulating Factor Receptor,Hematopoietic Growth Factor Receptor,Colony Stimulating Factor Receptor,Colony Stimulating Factor Receptors,Receptor, Colony-Stimulating Factor,Receptors, CSF,Receptors, Colony Stimulating Factor

Related Publications

A de Gentile, and M H Schlageter, and I Krawice, and H Dombret, and Y Najean, and C Chomienne, and M E Toubert
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
A de Gentile, and M H Schlageter, and I Krawice, and H Dombret, and Y Najean, and C Chomienne, and M E Toubert
November 1999, Nihon rinsho. Japanese journal of clinical medicine,
A de Gentile, and M H Schlageter, and I Krawice, and H Dombret, and Y Najean, and C Chomienne, and M E Toubert
July 2003, Blood,
A de Gentile, and M H Schlageter, and I Krawice, and H Dombret, and Y Najean, and C Chomienne, and M E Toubert
March 1999, Indian journal of cancer,
A de Gentile, and M H Schlageter, and I Krawice, and H Dombret, and Y Najean, and C Chomienne, and M E Toubert
August 1994, The Journal of dermatology,
A de Gentile, and M H Schlageter, and I Krawice, and H Dombret, and Y Najean, and C Chomienne, and M E Toubert
January 1990, Progress in clinical and biological research,
A de Gentile, and M H Schlageter, and I Krawice, and H Dombret, and Y Najean, and C Chomienne, and M E Toubert
January 1998, Pediatric hematology and oncology,
A de Gentile, and M H Schlageter, and I Krawice, and H Dombret, and Y Najean, and C Chomienne, and M E Toubert
October 1988, Seminars in oncology,
A de Gentile, and M H Schlageter, and I Krawice, and H Dombret, and Y Najean, and C Chomienne, and M E Toubert
September 2016, Journal of leukocyte biology,
A de Gentile, and M H Schlageter, and I Krawice, and H Dombret, and Y Najean, and C Chomienne, and M E Toubert
December 1998, Leukemia research,
Copied contents to your clipboard!